BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34884571)

  • 1. L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model.
    Corremans R; D'Haese PC; Vervaet BA; Verhulst A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect.
    Corremans R; Vervaet BA; Dams G; D'Haese PC; Verhulst A
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
    Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
    Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
    Erley CM; Heyne N; Friedrich B; Schmidt T; Strobel U; Wehrmann M; Osswald H
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):780-8. PubMed ID: 12409987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of NG-nitro-L-arginine methyl ester and insulin on nitric oxide inhibition and pathology in experimental diabetic rat liver.
    Ozden H; Tekin N; Akyuz F; Gurer F; Ustuner MC; Kucuk F; Guven G; Yaylak F
    Saudi Med J; 2009 Jan; 30(1):30-4. PubMed ID: 19139769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of metformin and/or glibenclamide with losartan reverse N
    Moke EG; Omogbai EKI; Osagie-Eweka SDE; Uchendu AP; Omogbiya AI; Ben-Azu B; Eduviere AT; Edje KE; Umukoro EK; Anachuna KK; Asiwe JN; Ahante E; Oghoghovwe IJ
    Microvasc Res; 2023 May; 147():104497. PubMed ID: 36738987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Choi KC; Lee SC; Kim SW; Kim NH; Lee JU; Kang YJ
    Korean J Intern Med; 1999 Jan; 14(1):32-41. PubMed ID: 10063312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
    Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
    Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
    J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced hyperglycemia is decreased by nitric oxide inhibition.
    Catanzaro OL; Marina-Prendes MG; Hope SI; Zuccollo A; Dominguez A
    Braz J Med Biol Res; 1994 Aug; 27(8):2043-7. PubMed ID: 7749393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
    Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
    J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of the nitric oxide synthase inhibitor to stimulate duodenal bicarbonate secretion in streptozotocin-diabetic rats.
    Takehara K; Tashima K; Kato S; Takeuchi K
    Life Sci; 1997; 60(17):1505-14. PubMed ID: 9126871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D; Schwartz IF; Blantz RC
    J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
    Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats.
    Schulz A; Schütten-Faber S; Schulte L; Unland J; Kossmehl P; Kreutz R
    Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
    Anderson S; Chapman JG; Oyama TT; Komers R
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
    Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
    Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes.
    Mattar AL; Fujihara CK; Ribeiro MO; de Nucci G; Zatz R
    Nephron; 1996; 74(1):136-43. PubMed ID: 8883032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility of diabetic rat gastric mucosa to food deprivation during cold stress.
    Korolkiewicz R; Tashima K; Kubomi M; Kato S; Takeuchi K
    Digestion; 1999; 60(6):528-37. PubMed ID: 10545722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.